ici 153066 has been researched along with miconazole in 6 studies
Studies (ici 153066) | Trials (ici 153066) | Recent Studies (post-2010) (ici 153066) | Studies (miconazole) | Trials (miconazole) | Recent Studies (post-2010) (miconazole) |
---|---|---|---|---|---|
19 | 0 | 0 | 2,309 | 238 | 476 |
Protein | Taxonomy | ici 153066 (IC50) | miconazole (IC50) |
---|---|---|---|
Metabotropic glutamate receptor 6 | Homo sapiens (human) | 6.5 | |
Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.4 | |
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 5.314 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Cytochrome P450 1A2 | Mus musculus (house mouse) | 4.55 | |
Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | 4.55 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 4.55 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.16 | |
Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.8 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.939 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 4.336 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.197 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.4938 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.966 | |
Adenosine receptor A3 | Homo sapiens (human) | 2.811 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 1.32 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 3.971 | |
Aromatase | Homo sapiens (human) | 0.6 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.2 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 5.482 | |
Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 3.7 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 7.089 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.598 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 3.154 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 7.8 | |
Substance-K receptor | Homo sapiens (human) | 4.839 | |
D(1A) dopamine receptor | Homo sapiens (human) | 6.247 | |
Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 5.8 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.939 | |
Thromboxane-A synthase | Homo sapiens (human) | 0.263 | |
Histamine H2 receptor | Homo sapiens (human) | 6.75 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.046 | |
Substance-P receptor | Homo sapiens (human) | 6.813 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.907 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 5.314 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.778 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.008 | |
Mu-type opioid receptor | Homo sapiens (human) | 6.059 | |
D(3) dopamine receptor | Homo sapiens (human) | 3.199 | |
Delta-type opioid receptor | Homo sapiens (human) | 3.387 | |
Kappa-type opioid receptor | Homo sapiens (human) | 6.594 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 5.545 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
Cholinesterase | Equus caballus (horse) | 5.55 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.701 | |
Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.2 | |
Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 6.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
Cauwenbergh, G | 1 |
Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
Beggs, WH; Hughes, CE | 1 |
Abruzzo, GK; Capizzi, TP; Fromtling, RA; Giltinan, DM | 1 |
Espinel-Ingroff, A; Kerkering, TM; Shadomy, S | 1 |
6 other study(ies) available for ici 153066 and miconazole
Article | Year |
---|---|
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
Irrelevance of growth phase with respect to the Bay n 7133 and ICI 153,066 susceptibilities of Candida albicans.
Topics: Anti-Bacterial Agents; Candida albicans; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles | 1986 |
Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.
Topics: Amphotericin B; Animals; Antifungal Agents; Female; Flucytosine; Luminescent Measurements; Mice; Miconazole; Oxygen Consumption; Phagocytes; Spleen; Triazoles | 1986 |
In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
Topics: Antifungal Agents; Arthrodermataceae; Blastomyces; Candida; Coccidioides; Cryptococcus neoformans; Drug Evaluation, Preclinical; Histoplasma; Imidazoles; Ketoconazole; Miconazole; Morpholines; Sporothrix; Triazoles | 1984 |